DEPAKOTE CP Drug Patent Profile
✉ Email this page to a colleague
When do Depakote Cp patents expire, and when can generic versions of Depakote Cp launch?
Depakote Cp is a drug marketed by Abbott and is included in one NDA.
The generic ingredient in DEPAKOTE CP is divalproex sodium. There are eighteen drug master file entries for this compound. Forty suppliers are listed for this compound. Additional details are available on the divalproex sodium profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Depakote Cp
A generic version of DEPAKOTE CP was approved as divalproex sodium by APOTEX on July 29th, 2008.
Summary for DEPAKOTE CP
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 67 |
Clinical Trials: | 97 |
Formulation / Manufacturing: | see details |
DailyMed Link: | DEPAKOTE CP at DailyMed |
Recent Clinical Trials for DEPAKOTE CP
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Puma Biotechnology, Inc. | Phase 1/Phase 2 |
Virginia Commonwealth University | Phase 1/Phase 2 |
Barretos Cancer Hospital | Early Phase 1 |
US Patents and Regulatory Information for DEPAKOTE CP
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Abbott | DEPAKOTE CP | divalproex sodium | TABLET, DELAYED RELEASE;ORAL | 019794-001 | Jul 11, 1990 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Abbott | DEPAKOTE CP | divalproex sodium | TABLET, DELAYED RELEASE;ORAL | 019794-002 | Jul 11, 1990 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for DEPAKOTE CP
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Abbott | DEPAKOTE CP | divalproex sodium | TABLET, DELAYED RELEASE;ORAL | 019794-002 | Jul 11, 1990 | ⤷ Try a Trial | ⤷ Try a Trial |
Abbott | DEPAKOTE CP | divalproex sodium | TABLET, DELAYED RELEASE;ORAL | 019794-002 | Jul 11, 1990 | ⤷ Try a Trial | ⤷ Try a Trial |
Abbott | DEPAKOTE CP | divalproex sodium | TABLET, DELAYED RELEASE;ORAL | 019794-001 | Jul 11, 1990 | ⤷ Try a Trial | ⤷ Try a Trial |
Abbott | DEPAKOTE CP | divalproex sodium | TABLET, DELAYED RELEASE;ORAL | 019794-001 | Jul 11, 1990 | ⤷ Try a Trial | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for DEPAKOTE CP
See the table below for patents covering DEPAKOTE CP around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Australia | 538751 | ⤷ Try a Trial | |
Italy | 1148718 | SALE MISTO DI ACIDO VALPROICO | ⤷ Try a Trial |
Italy | 8024207 | ⤷ Try a Trial | |
European Patent Office | 0034172 | MIXED SALT OF VALPROIC ACID | ⤷ Try a Trial |
>Country | >Patent Number | >Title | >Estimated Expiration |